Tag: generic drug delay
30-Month Stay: How Litigation Delays Generic Drug Approval
Dec, 11 2025
The 30-month stay under the Hatch-Waxman Act lets brand drug companies delay generic approval by filing patent lawsuits. This legal tool, meant to protect innovation, often extends drug monopolies by years-costing patients billions.
Read Article→Categories
online pharmacy
medication safety
generic drugs
side effects
pharmacovigilance
Hatch-Waxman Act
medication side effects
GoodRx coupons
dosage
counterfeit drugs
patent litigation
insomnia treatment
generic substitution
drug interactions
medication adherence
drug safety
bioequivalence
benefits
pharmacy alternatives
pain relief